Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2

9 Jan 2016

Abstract excerpt

// Zhiqiang Ye 1, * , Shengli Yin 2, * , Zhongzhen Su 3 , Mingjun Bai 4 , Haibo Zhang 5 , Ziqing Hei 6 , Songwang Cai 7 1 Department of Emergency, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China 2 Department of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China 3 Department of Ultrasonography, The Third Affiliated Hospital, Sun Yat-sen University,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to FOXO transcription factor regulation
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27229528
DOI: 10.18632/oncotarget.6852

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2PMID 27229528Read ↗

miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting METSemantic proximity Read ↗

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung CancerSemantic proximity Read ↗

MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.Semantic proximity Read ↗

Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins.Semantic proximity Read ↗

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin ResistanceSemantic proximity Read ↗

Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2Semantic proximity Read ↗

LMNA Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the Epithelial-Mesenchymal Transition via the FGFR/MAPK/c-fos Signaling Pathway.Semantic proximity Read ↗

Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancerSemantic proximity Read ↗

Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.Semantic proximity Read ↗

MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells.Semantic proximity Read ↗

Hypoxia‐induced microRNA‐301b regulates apoptosis by targeting Bim in lung cancerSemantic proximity Read ↗

ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.